These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11547059)

  • 21. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.
    Kodama J; Shinyo Y; Hasengaowa ; Kusumoto T; Seki N; Nakamura K; Hongo A; Hiramatsu Y
    Oncol Rep; 2005 Jul; 14(1):89-92. PubMed ID: 15944773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13].
    Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ
    Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of exogenous expression of heparanase gene on invasive ability of colorectal cancer cell line HT29].
    Liu Y; Ding YQ; Xin XY; Han LF; Liang L
    Ai Zheng; 2005 Dec; 24(12):1427-30. PubMed ID: 16351786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer.
    Li M; Song T; Yin ZF; Na YQ
    Chin Med J (Engl); 2007 Mar; 120(6):469-73. PubMed ID: 17439739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
    Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
    J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samples.
    Wang Z; Zhang X; Xu H; Zhou X; Jiang L; Lu C
    J Surg Oncol; 2005 May; 90(2):59-65. PubMed ID: 15844185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer.
    Boorjian S; Tickoo SK; Mongan NP; Yu H; Bok D; Rando RR; Nanus DM; Scherr DS; Gudas LJ
    Clin Cancer Res; 2004 May; 10(10):3429-37. PubMed ID: 15161698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparanase expression in primary and metastatic pancreatic cancer.
    Koliopanos A; Friess H; Kleeff J; Shi X; Liao Q; Pecker I; Vlodavsky I; Zimmermann A; Büchler MW
    Cancer Res; 2001 Jun; 61(12):4655-9. PubMed ID: 11406531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.
    Lascombe I; Clairotte A; Fauconnet S; Bernardini S; Wallerand H; Kantelip B; Bittard H
    Clin Cancer Res; 2006 May; 12(9):2780-7. PubMed ID: 16675571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of heparanase mRNA and its clinical significance in primary hepatocellular carcinoma].
    Zhang YL; Fu ZR; Ding GS; Fu H; Wang YH; Wang Q
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):359-61. PubMed ID: 12921566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increased expression of heparanase mRNA is correlated with metastasis of gastric carcinoma and is probably correlated with c-met protein].
    Cai YG; Fang DC; Yang SM; Luo YH; Yang MH; Wang DX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):974-8. PubMed ID: 15312528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
    J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparanase expression in endometrial cancer: analysis of immunohistochemistry.
    Inamine M; Nagai Y; Hirakawa M; Mekaru K; Yagi C; Masamoto H; Aoki Y
    J Obstet Gynaecol; 2008 Aug; 28(6):634-7. PubMed ID: 19003663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COX-2 induction by heparanase in the progression of breast cancer.
    Imada T; Matsuoka J; Nobuhisa T; Okawa T; Murata T; Tabuchi Y; Shirakawa Y; Ohara N; Gunduz M; Nagatsuka H; Umeoka T; Yamamoto Y; Nakajima M; Tanaka N; Naomoto Y
    Int J Mol Med; 2006 Feb; 17(2):221-8. PubMed ID: 16391819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.